Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioAffinity Technologies

BioAffinity Technologies
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$5M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of cancer diagnostic devices designed to test, detect, and treat cancer cells. The company technology analyzes a person's sputum, or phlegm, to find cancer cells that have sloughed off a lung tumor during collection of the sample, and it focuses on non-invasive, early-stage cancer screening, and diagnosis, enabling medical professionals to detect early-stage lung cancer.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • The University of Texas San Antonio
  • One UTSA Circle
  • San Antonio, TX 78249
  • United States

+1 (210) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioAffinity Technologies’s full profile, request a free trial.

BioAffinity Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 15-May-2018 $5M 00.00 Completed Startup
2. Angel (individual) 21-Jul-2017 00.000 00.00 0000 Completed Startup
1. Corporate 09-Mar-2017 $150K $150K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BioAffinity Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00.0 00.0 00 00.0 00
To view this company’s complete Cap Table, request access »

BioAffinity Technologies Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
San Antonio Development Corporation Other Minority 000 0000 000000 0

BioAffinity Technologies Executive Team (4)

Name Title Board
Seat
Contact
Info
Maria Zannes JD Chief Executive Officer, President & Board Member
Michael Edwards Chief Financial Officer & Vice President
Vivienne Rebel Ph.D Chief Medical and Science Officer & Executive Vice President, Research & Development
Steven Cantor Co-Founder

BioAffinity Technologies Board Members (8)

Name Representing Role Since Contact
Info
Barry Frankel BioAffinity Technologies Board Member 000 0000
Gary Rubin BioAffinity Technologies Board Member 000 0000
Maria Zannes JD BioAffinity Technologies Chief Executive Officer, President & Board Member 000 0000
Myron Holubiak Self Board Member 000 0000
Peter Knight JD Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »